New technologies advance treatment options for patients with arrhythmia disorders, HF
VIDEO: Michael J. Reardon, MD, discusses CoreValve system advances, new data
Lipid Forum II Highlights
Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients with History of Peripheral Arterial Disease
SAN FRANCISCO — Michael J. Reardon, MD, of the Methodist DeBaket Heart & Vascular Center in Houston, Texas reviews “what’s new with the CoreValve family” at the annual TCT Scientific Symposium.
Launching with the recently FDA-approved Evolut R (Medtronic), Reardon highlights why the next-generation system represents such a big advance in the United States and details key data coming out of the meeting.
This activity is supported by an educational grant from Merck & Co., Inc.
Optimal testing strategy for patients with suspected CAD remains unclear
Keith C. Ferdinand, MD, a front-runner in patient care
Novel mechanism, potential treatment strategies for CVD in patients with HIV
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.